NO20042365L - Kombinasjonsterapi omfattende ZD6474 og et taxan - Google Patents

Kombinasjonsterapi omfattende ZD6474 og et taxan

Info

Publication number: NO20042365L
Authority: NO; Norway
Prior art keywords: taxane; combination therapy; therapy; combination
Prior art date: 2001-11-08

Application number

NO20042365A

Other languages

English (en)

Other versions

NO328048B1 (no

Inventor

Stephen Robert Wedge

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-08

Filing date

2004-06-07

Publication date

2004-06-07

2004-06-07 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-06-07 Publication of NO20042365L publication Critical patent/NO20042365L/no

2009-11-16 Publication of NO328048B1 publication Critical patent/NO328048B1/no

Links

229940123237 Taxane Drugs 0.000 title 1
238000002648 combination therapy Methods 0.000 title 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20042365A 2001-11-08 2004-06-07 Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom NO328048B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0126879.6A GB0126879D0 (en)	2001-11-08	2001-11-08	Combination therapy
PCT/GB2002/005021 WO2003039551A1 (en)	2001-11-08	2002-11-06	Combination therapy comprising zd6474 and a taxane

Publications (2)

Publication Number	Publication Date
NO20042365L true NO20042365L (no)	2004-06-07
NO328048B1 NO328048B1 (no)	2009-11-16

Family

ID=9925430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042365A NO328048B1 (no)	2001-11-08	2004-06-07	Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom

Country Status (22)

Country	Link
US (2)	US20050043395A1 (no)
EP (1)	EP1446124B1 (no)
JP (1)	JP4694127B2 (no)
KR (1)	KR100959607B1 (no)
CN (1)	CN1298328C (no)
AR (1)	AR037346A1 (no)
AT (1)	ATE335488T1 (no)
AU (1)	AU2002337382B2 (no)
BR (1)	BR0213906A (no)
CA (1)	CA2464758C (no)
CY (1)	CY1106259T1 (no)
DE (1)	DE60213845T2 (no)
DK (1)	DK1446124T3 (no)
ES (1)	ES2269769T3 (no)
GB (1)	GB0126879D0 (no)
IL (2)	IL161744A0 (no)
MX (1)	MXPA04004355A (no)
NO (1)	NO328048B1 (no)
NZ (1)	NZ532525A (no)
PT (1)	PT1446124E (no)
WO (1)	WO2003039551A1 (no)
ZA (1)	ZA200403455B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1244647E (pt) *	1999-11-05	2006-10-31	Astrazeneca Ab	Derivados de quinazolina como inibidores de vegf
GB0008269D0 (en)	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
IL151626A0 (en) *	2000-04-07	2003-04-10	Astrazeneca Ab	Quinazoline compounds
EP2292615A1 (en) *	2002-02-01	2011-03-09	AstraZeneca AB	Quinazoline compounds
TW200813014A (en) *	2002-03-28	2008-03-16	Astrazeneca Ab	Quinazoline derivatives
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
RU2350618C2 (ru)	2002-11-04	2009-03-27	Астразенека Аб	ПРОИЗВОДНЫЕ ХИНАЗОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Src ТИРОЗИНКИНАЗЫ
DE602004032310D1 (de) *	2003-02-13	2011-06-01	Astrazeneca Ab	Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
JP2007526886A (ja) *	2003-07-10	2007-09-20	アストラゼネカアクチボラグ	血管新生および／または血管透過性増大に関連する疾患の処置における、プラチナ系抗腫瘍剤および任意の電離放射線と組み合わせてのキナゾリン誘導体ｚｄ６４７４の使用
JP2007511509A (ja) *	2003-11-14	2007-05-10	ファルマ・マール・ソシエダード・アノニマ	Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
GB0406445D0 (en) *	2004-03-23	2004-04-28	Astrazeneca Ab	Combination therapy
GB0411378D0 (en) *	2004-05-21	2004-06-23	Astrazeneca Ab	Pharmaceutical compositions
CA2571421A1 (en) *	2004-06-24	2006-01-05	Nicholas Valiante	Compounds for immunopotentiation
KR20070072543A (ko) *	2004-09-27	2007-07-04	아스트라제네카 아베	Ｚｄ6474 및 이마티닙을 포함하는 병합법
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
GB0519879D0 (en)	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
CA2631764A1 (en) *	2005-12-22	2007-06-28	Astrazeneca Ab	Combination of zd6474 and pemetrexed
US20080045589A1 (en) *	2006-05-26	2008-02-21	Susan Kelley	Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
WO2008037996A1 (en) *	2006-09-29	2008-04-03	Astrazeneca Ab	Combination of zd6474 and bevacizumab for cancer therapy
US20080190689A1 (en) *	2007-02-12	2008-08-14	Ballard Ebbin C	Inserts for engine exhaust systems
MX2010012442A (es) *	2008-05-13	2011-10-11	Astrazeneca Ab	Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina.
WO2010061208A2 (en) *	2008-11-03	2010-06-03	Astrazeneca Ab	Therapeutic treatment 555
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法
CN106478598B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种凡德他尼水合物晶体及其制备方法
IL303606A (en) *	2020-12-22	2023-08-01	Hanmi Pharmaceutical Co Ltd	A new QUINAZOLINE derivative compound as an SOS1 inhibitor, and its use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5565478A (en) *	1994-03-14	1996-10-15	The United States Of America As Represented By The Department Of Health & Human Services	Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
PT910382E (pt) *	1996-04-26	2003-10-31	Genaera Corp	Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
GB9727524D0 (en) *	1997-12-31	1998-02-25	Pharmacia & Upjohn Spa	Synergistic antitumor composition containing a biologically active ureido compound
EP1154782A4 (en) *	1999-02-24	2002-09-25	Uab Research Foundation	TAXAN DERIVATIVES FOR TARGETED CANCER THERAPY
EP1179541B1 (en) *	1999-04-28	2004-06-16	Board Of Regents, The University Of Texas System	Compositions and methods for cancer treatment by selectively inhibiting VEGF
PT1244647E (pt) *	1999-11-05	2006-10-31	Astrazeneca Ab	Derivados de quinazolina como inibidores de vegf
TWI310684B (en) *	2000-03-27	2009-06-11	Bristol Myers Squibb Co	Synergistic pharmaceutical kits for treating cancer
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
AU2003249000B2 (en) *	2002-08-09	2007-04-05	Astrazeneca Ab	Combination of ZD6474, an inhibitor of the vasuclar endothelial growth factor receptor, with radiotherapy in the treatment of cancer
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
DE602004032310D1 (de) *	2003-02-13	2011-06-01	Astrazeneca Ab	Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11
JP2007526886A (ja) *	2003-07-10	2007-09-20	アストラゼネカアクチボラグ	血管新生および／または血管透過性増大に関連する疾患の処置における、プラチナ系抗腫瘍剤および任意の電離放射線と組み合わせてのキナゾリン誘導体ｚｄ６４７４の使用
KR20070072543A (ko) *	2004-09-27	2007-07-04	아스트라제네카 아베	Ｚｄ6474 및 이마티닙을 포함하는 병합법
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
CA2631764A1 (en) *	2005-12-22	2007-06-28	Astrazeneca Ab	Combination of zd6474 and pemetrexed
WO2008037996A1 (en) *	2006-09-29	2008-04-03	Astrazeneca Ab	Combination of zd6474 and bevacizumab for cancer therapy

2001
- 2001-11-08 GB GBGB0126879.6A patent/GB0126879D0/en not_active Ceased
2002
- 2002-11-06 AT AT02772624T patent/ATE335488T1/de active
- 2002-11-06 BR BR0213906-5A patent/BR0213906A/pt not_active IP Right Cessation
- 2002-11-06 EP EP02772624A patent/EP1446124B1/en not_active Expired - Lifetime
- 2002-11-06 DE DE60213845T patent/DE60213845T2/de not_active Expired - Lifetime
- 2002-11-06 KR KR1020047007020A patent/KR100959607B1/ko not_active Expired - Fee Related
- 2002-11-06 IL IL16174402A patent/IL161744A0/xx unknown
- 2002-11-06 MX MXPA04004355A patent/MXPA04004355A/es active IP Right Grant
- 2002-11-06 DK DK02772624T patent/DK1446124T3/da active
- 2002-11-06 ES ES02772624T patent/ES2269769T3/es not_active Expired - Lifetime
- 2002-11-06 CA CA2464758A patent/CA2464758C/en not_active Expired - Fee Related
- 2002-11-06 WO PCT/GB2002/005021 patent/WO2003039551A1/en not_active Ceased
- 2002-11-06 CN CNB028267958A patent/CN1298328C/zh not_active Expired - Fee Related
- 2002-11-06 AU AU2002337382A patent/AU2002337382B2/en not_active Ceased
- 2002-11-06 NZ NZ532525A patent/NZ532525A/en not_active IP Right Cessation
- 2002-11-06 US US10/494,704 patent/US20050043395A1/en not_active Abandoned
- 2002-11-06 JP JP2003541842A patent/JP4694127B2/ja not_active Expired - Fee Related
- 2002-11-06 PT PT02772624T patent/PT1446124E/pt unknown
- 2002-11-08 AR ARP020104292A patent/AR037346A1/es not_active Application Discontinuation
2004
- 2004-05-03 IL IL161744A patent/IL161744A/en not_active IP Right Cessation
- 2004-05-06 ZA ZA200403455A patent/ZA200403455B/en unknown
- 2004-06-07 NO NO20042365A patent/NO328048B1/no not_active IP Right Cessation
2006
- 2006-11-09 CY CY20061101619T patent/CY1106259T1/el unknown
2011
- 2011-11-07 US US13/290,730 patent/US20120252827A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO328048B1 (no)	2009-11-16
IL161744A (en)	2012-01-31
DK1446124T3 (da)	2006-11-13
CN1612738A (zh)	2005-05-04
CN1298328C (zh)	2007-02-07
DE60213845T2 (de)	2007-03-29
KR100959607B1 (ko)	2010-05-27
US20050043395A1 (en)	2005-02-24
AU2002337382B2 (en)	2008-06-12
AR037346A1 (es)	2004-11-03
ZA200403455B (en)	2005-08-29
CY1106259T1 (el)	2011-06-08
JP4694127B2 (ja)	2011-06-08
EP1446124A1 (en)	2004-08-18
WO2003039551A1 (en)	2003-05-15
MXPA04004355A (es)	2004-08-11
ES2269769T3 (es)	2007-04-01
PT1446124E (pt)	2006-12-29
CA2464758C (en)	2010-09-28
NZ532525A (en)	2006-11-30
HK1068546A1 (en)	2005-04-29
BR0213906A (pt)	2004-08-31
KR20050043779A (ko)	2005-05-11
IL161744A0 (en)	2005-11-20
CA2464758A1 (en)	2003-05-15
JP2005511597A (ja)	2005-04-28
DE60213845D1 (de)	2006-09-21
ATE335488T1 (de)	2006-09-15
EP1446124B1 (en)	2006-08-09
GB0126879D0 (en)	2002-01-02
US20120252827A1 (en)	2012-10-04

Legal Events

Date	Code	Title	Description
2014-06-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
DK1446124T3 (da)	2006-11-13	Kombinationsterapi, der omfatter ZD6474 og et taxan
DK1513873T3 (da)	2014-11-03	Terapeutiske epitoper og anvendelser deraf
EP1453581A4 (en)	2007-07-11	Object recognition toys and games
EP1412378A4 (en)	2006-09-20	APTAMERS AND ANTIAPTAMERS
GB2421695B (en)	2006-11-08	Gaming environment including portable transaction devices
DK1370128T3 (da)	2014-05-26	Kombineret ballepresse og ballevikler
DK1519770T3 (da)	2013-09-30	Elektroporesisk indretning og indsprøjtningsapparat
DE60144138D1 (de)	2011-04-14	Lichtemittierende Vorrichtungen und lichtemittierende Anzeigevorrichtungen
NO20035559L (no)	2004-02-16	Personlig spilleanordning
DE60230583D1 (de)	2009-02-12	Spielvorrichtung und Spielprogramm
FR2823558B1 (fr)	2005-10-21	Glaciere portable
GB0203933D0 (en)	2002-04-03	Portable dummy sterilizer
PT1558595E (pt)	2010-01-15	Piperazinil e diazepanil benzamidas e benzotioamidas
NO20034022L (no)	2003-09-11	En kombinasjon omfattende combretastatin og anticancermidler
GB0111505D0 (en)	2001-07-04	A portable sauna
AU148766S (en)	2002-08-05	Portable drill
DK1456377T3 (da)	2019-09-23	Syn3-sammensætninger og fremgangsmåder
NO20033709L (no)	2003-10-22	Medisinske preparater omfattende Diklofenak og Ornoprostil
NO20032821D0 (no)	2003-06-19	Sea-trosy og beslektede fremgangsmåter
SI1446124T1 (sl)	2006-12-31	Kombinacijska terapija, ki obsega ZD6474 in taksan
DE60219418D1 (de)	2007-05-24	Silanylphenole und -naphthole
TW570251U (en)	2004-01-01	Portable exercise and worship counter device
GB2380689B (en)	2004-12-29	Portable step
PL112305U1 (en)	2002-12-30	Portable game
GB0100515D0 (en)	2001-02-21	Music teaching game